Pengyuan Wang | Pancreatitis | Young Researcher Award

Mr. Pengyuan Wang | Pancreatitis | Young Researcher Award

Department of Gastroenterology, Changhai Hospital, Naval Medical University | China

Mr. Pengyuan Wang is an accomplished biomedical researcher and clinician specializing in gastroenterology and translational pharmacology. He obtained a Bachelor’s degree in Clinical Medicine, followed by a Ph.D. in Pharmacology, and further strengthened his academic foundation through postdoctoral training in Gastroenterology. He is currently affiliated with leading clinical and research centers in China, where he integrates clinical insight with mechanistic research to address complex gastrointestinal diseases. His professional experience bridges patient-oriented practice and laboratory-based investigation, enabling a strong bench-to-bedside research approach. Mr. Wang’s primary research interest focuses on the metabolic mechanisms underlying pancreatitis, with particular emphasis on identifying key molecular pathways involved in disease initiation and progression. In parallel, he is actively engaged in drug screening and pharmacological evaluation, aiming to discover and optimize therapeutic candidates for pancreatitis and related metabolic disorders. His work contributes to improving diagnostic strategies and advancing targeted treatments in gastroenterology. Recognized for his rigorous scientific approach and interdisciplinary expertise, he has received academic acknowledgment through competitive research training and scholarly contributions. Overall, Mr. Wang’s research continues to enhance the understanding of pancreatitis pathophysiology and supports the development of innovative therapeutic interventions with significant clinical relevance.

View ORCID Profile

Featured Publications

Xiang Wu | Medical Biomaterials | Research Excellence Award

Dr. Xiang Wu | Medical Biomaterials | Research Excellence Award

Ningbo University | China

Dr. Xiang Wu is a dedicated medical researcher and clinician currently serving at Ningbo Medical Center Li Huili Hospital, Health Science Center, Ningbo University, where he actively contributes to interdisciplinary biomedical research. With a strong academic foundation in medical sciences and biomaterials, his education and professional training have enabled him to bridge clinical needs with engineering-driven solutions. His experience spans hospital-based research and university-level scientific collaboration, focusing on translating laboratory innovations into practical medical applications. Dr. Wu’s primary research interests include functional hydrogels for tissue adhesion, hemostasis, postoperative repair, and advanced biomaterials such as bone and joint materials, adhesive systems, and Janus patches. In parallel, he investigates molecular regulatory mechanisms involving lncRNA and circRNA in cancers, particularly pancreatic and bladder cancer, highlighting his integrative approach that combines materials science with molecular medicine. Since 2020, his scholarly contributions have gained notable academic recognition, reflected in a strong citation record and h-index, underscoring the impact of his research on addressing clinical treatment challenges. His work aligns closely with modern translational medicine, emphasizing innovation, clinical relevance, and interdisciplinary collaboration. In conclusion, Dr. Wu represents a new generation of clinician-scientists whose research advances both biomedical materials and molecular oncology, contributing meaningfully to improved therapeutic strategies and future medical technologies.

Profiles: Orcid | Google Scholar

Featured Publications

 

Nicholas Candy | Surgical Hydrogels | Research Excellence Award

Dr. Nicholas Candy | Surgical Hydrogels | Research Excellence Award

University of Adelaide | Australia

Dr. Nicholas Candy is an accomplished neurosurgeon and academic whose career blends advanced clinical expertise with impactful research. He holds a Master of Surgery in Neurosurgery from the University of Sydney and completed his PhD at the University of Adelaide, where he later progressed to roles as Clinical Lecturer and Senior Clinical Lecturer. His extensive clinical experience spans multiple accredited registrar positions across leading Australian hospitals, including the Royal Adelaide Hospital, Royal Brisbane and Women’s Hospital, and Flinders Medical Centre. He has cultivated strong research interests in pituitary surgery, postoperative outcomes, neuro-endocrine preservation, and innovations that reduce surgical scarring and complications. His role as Coordinating Principal Investigator in a Phase I trial on Chitogel and Deferiprone Gel reflects his commitment to translational research designed to enhance neurosurgical recovery. Dr. Candy has supervised doctoral research, contributed to international clinical studies, and carried out significant work in traumatic brain injury outcomes and neurosurgical quality-of-life assessments. His academic impact and contributions have earned him notable awards, including multiple prestigious research scholarships from the Royal Australasian College of Surgeons and recognition as the Sheldon College Young Alumnus of the Year. Overall, he stands out as a dedicated clinician-scientist advancing modern neurosurgical practice.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Ovenden, C., Mignone, E., Chapman, I., Torpy, D. J., Rankin, W., Jukes, A., Santoreneos, S., Candy, N., Psaltis, A., & De Sousa, S. M. C. (2026). “Early Postoperative Decline in Insulin-Like Growth Factor 1 (IGF-1) Predicts Surgical Remission of Acromegaly.” World Neurosurgery.

Candy, N. G., Barry, E. F., Tomatis, V. M., Patel, S., Miller, J., Ovenden, C., Nowicki, J., Hammam, E., Poonnoose, S., Sandler, S., et al. (2025). “Phase I Trial to Evaluate Safety of Deferiprone-Chitogel to Prevent Epidural Fibrosis in Lumbar Spine Surgery.” European Spine Journal.

Tong, J. Y., Candy, N. G., Sung, J., Jukes, A. K., & Selva, D. (2025). “In Reply: Transorbital Approach to the Cavernous Sinus After an Exenteration.” Operative Neurosurgery.

Tong, J. Y., Candy, N. G., Sung, J., Jukes, A. K., & Selva, D. (2025). “Transorbital Approach to the Cavernous Sinus After an Exenteration.” Operative Neurosurgery.

Candy, N. G., Jukes, A. K., Ooi, E. H., Valentine, R., Vrodos, N., Santoreneos, S., Floreani, S., Wormald, P.-J., & Psaltis, A. J. (2025). “The Evolution of Pituitary Surgery in an Australian Health Care Framework.” Journal of Neurological Surgery Part B: Skull Base.

Candy, N. G., Zhang, A. S., Jukes, A. K., & Wormald, P. J. (2025). “Sphenoid sinusitis with extradural empyema in a paediatric patient.” Journal of Clinical Neuroscience.

Mansour, L. T., Candy, N., Nowicki, J., Jukes, A., Chryssidis, S., & Harding, M. (2024). “An infratentorial dural arteriovenous fistula mimicking cervical myelopathy: A case report.” Clinical Neurology and Neurosurgery.

Prof. Jianli Liu | Chemical Toxicology | Best Researcher Award

Prof. Jianli Liu | Chemical Toxicology | Best Researcher Award

Liaoning University | China

Prof. Jianli Liu is a distinguished researcher and educator in the field of biotechnology and medical genetics, with a strong academic foundation spanning from a Bachelor’s and Master’s degree in Biotechnology at Shenyang Agricultural University to a Ph.D. in Medical Genetics from China Medical University, where his doctoral work focused on CDK2 expression regulated by STK15 in laryngeal carcinoma. He began his academic career as a tutor at Liaoning University, advancing through the roles of lecturer and associate professor, and currently serves as a professor at the Life Science School of Liaoning University. Prof. Liu’s research interests lie in molecular mechanisms of disease, cellular signaling pathways, and the protective effects of natural products such as polysaccharides, anthocyanins, and polyphenols against environmental stressors including high glucose and PM2.5-induced damage. He has led multiple nationally funded projects, including those supported by the National Natural Science Foundation of China and regional innovation programs, focusing on lung disease, β-cell protection, heavy metal pollution control, and therapeutic potentials of bioactive compounds. Recognized for his impactful contributions, Prof. Liu continues to advance interdisciplinary research bridging biotechnology, medicine, and environmental health, while inspiring future scientists through his teaching and mentorship.

Profile: Scopus

Featured Publications

Study on the causality of cathepsin on autoimmune diseases and cancer: evidence from mendelian randomization analysis

Cadmium induces the secretion of SASP factors regulated by MAPK and NF-κB signaling pathways in HEK293 cells: A possible mechanism of acute kidney damage induced by cadmium

Genetic Association of Chronic Pains and Analgesics With Telomere Length: A Mendelian Randomization Study

Cadmium exposure induces inflammation, oxidative stress and DNA damage in HUVEC and promotes THP-1 adhesion: A possible mechanism on the formation of atherosclerotic plaque

Assessments of Pollution Status and Human Health Risk of Potentially Toxic Elements in Primary Crops and Agricultural Soils in Guanajuato, Mexico

Association between cadmium exposure and the risk of cardiovascular outcomes: a meta-analysis